IMWG Conference Series ASH 2023 Published 2023-12-14 Download video MP4 360p Recommendations 1:05:42 Top Myeloma Research at ASH 2023 from a Patient Perspective 59:12 CAR T-cell Therapy: The Good, The Bad and The Long-Term 2022 1:01:16 ASH 2023 Myeloma Recap with Dr. Ben Derman 30:09 Highlights from ASH 2023: A Canadian Perspective on CLL 1:16:04 Post ASH23 Myeloma roundtable by the IACH 1:03:30 Treatments, Trials, & Hope with Dr. Jorge Castillo, January 19, 2023 06:18 ASH23: Isatuximab Combo in Iskia Trial for Pre- & Post-Transplant Treatment | Francesca Gay, MD, PhD 05:24 How Long Can I Live with CLL? (Chronic Lymphocytic Leukemia) | The Patient Story 16:43 ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3 16:28 The LATEST in Chronic Lymphocytic Leukemia (CLL) Treatments! | The Patient Story 1:00:25 How do mitochondria contribute to health and disease? - Peter McGuire 12:56 ASH23: Perseus Trial: DARA + VRd vs. Vrd Alone in ASCT-Eligible Patients | Pieter Sonneveld, MD, PhD 3:54:38 Optogenetics: Illuminating the Path toward Causal Neuroscience 44:53 Update in Multiple Myeloma 03:59 Noopur Raje, MD, Shares Myeloma Research Updates From ASH 2023 43:20 Extending Remissions for Newly Diagnosed Myeloma Patients | Seattle RT Oct 14, 2023 1:05:39 IMWG Conference Series: ASCO & EHA 2023 21:52 Making Watch and Wait Obsolete | Boston RT Sept 16, 2023 09:31 ASH 2023 | High-risk myeloma Similar videos 59:27 IMWG Conference Series: Reporting from ASH 2022 1:02:47 ASH 2017: IMWG Conference Series 1:03:51 Top Myeloma Research Presented at ASCO & EHA Webinar 2023 1:03:39 Top Myeloma Research Presented at ASH 2022 1:02:14 February 10, 2023 | Post ASH CME Series 2022: Multiple Myeloma 10:05 Key Multiple Myeloma Abstracts Presented at ASH 2022 52:50 ASH UPDATE with Aaron Goodman, MD PAPA HEME 01:36 ASH 22 | Dr Dimopoulos' perspective on the myeloma highlights presented at ASH 2022 03:42 2022 ASH Conference - Raymond Urbanski, MD, PhD 03:37 ASH Clinical News: January 2023 From the Desk Of... 01:38 What to Look Forward to at ASH | Ola Landgren, MD, PhD | ASH 2022 04:46 ASH 22 | CAR-T updates 05:30 ASH 22 | Frailty and high risk patients updates 1:12:04 Multiple Myeloma: a post-ASH22 summary More results